逆行式喉功能障碍和使用肉毒素治疗:系统性审查
Clara Helena Jönsson1, Christina Caroline Plaschke2
1University of Copenhagen, Blegdamsvej 3B, 2200, Copenhagen, Denmark. vsd141@alumni.ku.dk.
概括
逆行式喉功能障碍 (RCPD) 是一种新描述的疾病. 毒素 (BT) 注射是一种安全有效的治疗方法,大多数患者经历了显著的症状缓解,只有轻微的,暂时的副作用.
科学领域:
- 胃肠道学和耳鼻喉学
- 神经肌肉疾病 神经肌肉疾病
- 手术治疗学手术治疗学
背景情况:
- 逆行式喉功能障碍 (RCPD) 是一种最近发现的疾病,其特点是无法吐.
- 关键症状包括声,胸痛,胀气和过度膨胀,这些都是由喉肌肉功能障碍引起的.
研究的目的:
- 系统地审查RCPD的病因学,诊断和治疗.
- 评估毒素 (BT) 作为RCPD治疗的疗效和安全性.
主要方法:
- 对PubMed,Embase和Cochrane数据库进行了符合PRISMA的系统审查.
- 选了将肉毒毒素 (BT) 与RCPD描述结合的研究,包括13篇论文和472名患者.
主要成果:
- 症状学是主要的诊断方法 (82.4%).
- 毒素 (BT) 治疗显示出高效率,93.7%的患者在1-4周内出现效果,81.0%的患者在6个月内出现效果.
- 常见的症状包括无法吐 (99.8%) 和胸部疼痛/胀气 (95.4%). 轻度消化不良 (59.4%) 和反流 (35.4%) 是主要的并发症.
结论:
- 逆行式喉功能障碍 (RCPD) 正在获得认可,毒素 (BT) 已被证明是一种安全有效的治疗方法.
- 虽然有效,但需要进一步的研究来建立RCPD的国际诊断标准.
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Skeletal Muscle Relaxants: Therapeutic Uses
482
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
482


